Compare CADL & AVBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CADL | AVBH |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 284.5M |
| IPO Year | 2021 | N/A |
| Metric | CADL | AVBH |
|---|---|---|
| Price | $5.67 | $26.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $19.43 | ★ $29.17 |
| AVG Volume (30 Days) | ★ 976.9K | 74.4K |
| Earning Date | 11-13-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $22,129,000.00 |
| Revenue This Year | N/A | $19.35 |
| Revenue Next Year | N/A | $17.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.25 | $19.75 |
| 52 Week High | $13.68 | $27.99 |
| Indicator | CADL | AVBH |
|---|---|---|
| Relative Strength Index (RSI) | 52.75 | N/A |
| Support Level | $5.45 | N/A |
| Resistance Level | $6.14 | N/A |
| Average True Range (ATR) | 0.40 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 16.73 | 0.00 |
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.